,

Cyfra21-1

Supporting to diagnose Non-Small-Cell Lung Cancer (NSCLC)

Categories: ,

This test helps in the early detection of prostate diseases
such as enlarged prostate and prostatitis and
prostate cancer by quantifying PSA in male blood,
as well as observation of treatment effects and monitoring of recurrence.

Reviews

There are no reviews yet.

Be the first to review “Cyfra21-1”

Your email address will not be published. Required fields are marked *

Scroll to Top